Extinction of the HPV18 upstream regulatory region in cervical carcinoma cells after fusion with non-tumorigenic human keratinocytes under non-selective conditions.
'Universal fuser' clones of a human papillomavirus type 16 positive cervical carcinoma cell line (SiHa) were established to study the effect of a non-tumorigenic fusion partner on the regulation of a stably integrated chloramphenicol acetyltransferase (CAT) gene controlled by the HPV18 upstream regulatory region under non-selective conditions. The CAT expressing cells were fused with both non-tumorigenic, spontaneously immortalized human keratinocytes (HaCaT) and non-modified SiHa cells. The resulting hybrids were characterized by restriction enzyme fragment length polymorphism analysis and flow cytometry. While the non-selectable, HPV18-driven indicator gene is constitutively expressed in SiHa cells, the CAT activity is extinguished in SiHa x HaCaT cells, but still present in SiHa x SiHa hybrids. Examination of the cytokeratin expression pattern reveals that the keratinocyte phenotype seems not only to be dominant in terms of the extinction of the HPV18 regulatory region but also by the conservation of most of the differentiation markers of the non-tumorigenic fusion partner. Cycloheximide treatment and intracellular competition experiments using the transient COS7 fusion-amplification technique are accompanied by the reactivation of the marker gene in previously CAT- SiHa x HaCaT hybrids. These data strongly suggest that trans-acting negative regulatory factors derived from the non-malignant human keratinocytes are responsible for the extinction phenomenon.
Rösl
F
F
Institut für Angewandte Tumorvirologie, Deutsches Krebsforschungszentrum, Heidelberg, FRG.
Achtstätter
T
T
Bauknecht
T
T
Hutter
K J
KJ
Futterman
G
G
zur Hausen
H
H
D000818:Animals; D015152:Blotting, Northern; D002277:Carcinoma / Q000235:genetics* / Q000473:pathology; D002459:Cell Fusion; D002522:Chlorocebus aethiops; D015180:Electrophoresis, Gel, Two-Dimensional; D005260:Female; D015967:Gene Expression Regulation, Viral; D006801:Humans; D066298:In Vitro Techniques; D015603:Keratinocytes / Q000502:physiology*; D007633:Keratins / Q000737:chemistry / Q000378:metabolism; D027383:Papillomaviridae / Q000235:genetics*; D012150:Polymorphism, Restriction Fragment Length; D012333:RNA, Messenger / Q000235:genetics; D012045:Regulatory Sequences, Nucleic Acid; D012097:Repressor Proteins / Q000502:physiology; D014158:Transcription, Genetic; D014162:Transfection; D002583:Uterine Cervical Neoplasms / Q000235:genetics* / Q000473:pathology
D012333:RNA, Messenger; D012097:Repressor Proteins; D007633:Keratins